This session explores how a Controlled Drug Accountable Officer (CDAO) led the digital transformation of controlled drug (CD) management within an NHS Trust, addressing longstanding challenges with paper-based systems. It highlights the CDAO’s statutory responsibilities, the development of a compelling business case for digital change, and the Trust’s journey toward safer, more efficient CD governance. Attendees will gain insight into how moving to digital improved compliance, reduced risk, and delivered measurable outcomes such as time savings, enhanced auditability, and greater confidence in medicines management.

• -Understanding the current issues facing CDAOs
• -Understanding the advantages of electronic CD registers from an CD management and oversight perspective